Alpha Teknova, Inc. (TKNO) Financials

TKNO Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 138.4 million 38.7 million
2023-06-30 132.5 million 46.3 million
2023-03-31 141.0 million 48.9 million
2022-12-31 152.3 million 52.4 million

TKNO Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -5.4 million 1.0 million
2023-06-30 -6.2 million 1.1 million
2023-03-31 -12.0 million 1.0 million
2022-12-31 -12.8 million 1.0 million

TKNO Net Income

No data available :(

TKNO Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 32.1 million - 17.6 million
2023-06-30 23.7 million - 18.1 million
2023-03-31 30.2 million 22.0 million 18.9 million
2022-12-31 42.2 million - 20.3 million

TKNO Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 30.0 million
2023-06-30 28.3 million
2023-03-31 28.2 million
2022-12-31 28.2 million

TKNO Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 972000 1.4 million 6.1 million 2.4 million
2023-06-30 2.3 million 1.5 million 5.9 million 2.2 million
2023-03-31 4.3 million 1.4 million 7.3 million 2.3 million
2022-12-31 4.7 million 1.9 million 7.4 million 2.6 million

TKNO Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 8.2 million 6.7 million
2023-06-30 11.5 million 6.5 million
2023-03-31 9.1 million 6.7 million
2022-12-31 7.9 million 5.8 million

TKNO

Price: $2

52 week price:
1.62
4.27

Earnings Per Share: -1.38 USD

P/E Ratio: -2.55

Exchange: NGM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Volume: 32300

Market Capitalization: 104.6 million

Links: